SchemaZone Revenue and Competitors

Markham , ON Canada

Location

N/A

Total Funding

Consulting

Industry

Estimated Revenue & Valuation

  • SchemaZone's estimated annual revenue is currently $3.5M per year.(i)
  • SchemaZone's estimated revenue per employee is $154,000

Employee Data

  • SchemaZone has 23 Employees.(i)
  • SchemaZone grew their employee count by -38% last year.

SchemaZone's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.6M3245%N/AN/A
#2
$51.3M2126%N/AN/A
#3
$60M2481%N/AN/A
#4
$0.9M8-11%N/AN/A
#5
$29.9M13627%N/AN/A
#6
$12.7M6416%N/AN/A
#7
$2.2M17-6%N/AN/A
#8
$6.5M3732%N/AN/A
#9
$28.2M1287%N/AN/A
#10
$3.5M23-38%N/AN/A
Add Company

What Is SchemaZone?

A consulting, training and contracting firm headquartered right in the heart of Canada’s business and financial capital, Toronto. We are a success-driven firm that provides management advisory, training and contracting services customized to help companies from different industries solve business management problems and/or run, lead, and manage their complex projects and initiatives. We have begun from scratch, when a network of professionals, PhD holders, and highly skilled personnel bring to a business table their 15+ practical and academic years of experience to form up a concrete blueprint on which the company has been designed. Since then, we offer a combination of expertise, proficiency, and commitment leveraging our deep industry experience along with using analytical rigor to drive outstanding results for businesses.

keywords:N/A

N/A

Total Funding

23

Number of Employees

$3.5M

Revenue (est)

-38%

Employee Growth %

N/A

Valuation

N/A

Accelerator

SchemaZone News

2022-03-30 - Top employer brands converge at Ajman University's Virtual ...

... Nestle, UEMEDICAL, Henkel, Nomac, Veolia, Hikma Pharmaceuticals, Richemont, PRA Consultancy, Edutech Middle East, SchemaZone, DMCC,...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$3.6M2315%N/A
#2
$4.7M25-7%N/A
#3
$2.5M25N/AN/A
#4
$3.7M250%N/A
#5
$2.5M260%N/A